FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne de Boer

Research Profile

Devices

Nebulizers and Vaporizers

Procedures

Concepts & Ideas

Particle Size

Chemicals & Drugs

Occupations

Co-author Network

Publications

TOP 3
Floris Grasmeijer; Paul Hagedoorn; Henderik W Frijlink; Anne H de Boer
Characterisation of high dose aerosols from dry powder inhalers.
Wouter F Tonnis; Anne H de Boer; Henderik W Frijlink; Wouter L J Hinrichs; Gideon F Kersten; Jean-Pierre Amorij
Pulmonary vaccine delivery: a realistic approach?
Anne H de Boer; Paul Hagedoorn; Robert Woolhouse; Ed Wynn
Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne de Boer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Floris Grasmeijer; Paul Hagedoorn; Henderik W Frijlink; Anne H de Boer
Characterisation of high dose aerosols from dry powder inhalers.
International journal of pharmaceutics 2012;437(1-2):242-9.
2012: Wouter F Tonnis; Anne H de Boer; Henderik W Frijlink; Wouter L J Hinrichs; Gideon F Kersten; Jean-Pierre Amorij
Pulmonary vaccine delivery: a realistic approach?
Journal of aerosol medicine and pulmonary drug delivery 2012;25(5):249-60.
2012: Anne H de Boer; Paul Hagedoorn; Robert Woolhouse; Ed Wynn
Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.
The Journal of pharmacy and pharmacology 2012;64(9):1316-25.
2010: Thanh T Nguyen; Clinton Rambanapasi; Anne H de Boer; Henderik W Frijlink; Peter M v D Ven; Joop Vries de; Henk J Busscher; Kees v D Voort Maarschalk
A centrifuge method to measure particle cohesion forces to substrate surfaces: the use of a force distribution concept for data interpretation.
International journal of pharmaceutics 2010;393(1-2):88-95.
2009: Paul Munnik; Anne H de Boer; Jeroen Wissink; Paul Hagedoorn; Iwan Heskamp; Wilbur de Kruijf; Cees J M van Rijn; Henderik W Frijlink; Pieter Zanen
In vivo performance testing of the novel Medspray wet aerosol inhaler.
Journal of aerosol medicine and pulmonary drug delivery 2009;22(4):317-21.
2009: Gerrit S Zijlstra; Bart J Ponsioen; Sylvia A Hummel; Niek Sanders; W L J Hinrichs; Anne H de Boer; Henderik W Frijlink
Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation.
Pharmaceutical development and technology 2009;14(4):358-68.
2008: Anne H de Boer; Jeroen Wissink; Paul Hagedoorn; Iwan Heskamp; Wilbur de Kruijf; Ralf Bünder; Pieter Zanen; Paul Munnik; Cees van Rijn; Henderik W Frijlink
In vitro performance testing of the novel Medspray wet aerosol inhaler based on the principle of Rayleigh break-up.
Pharmaceutical research 2008;25(5):1186-92.
2008: M Weda; Pieter Zanen; Anne H de Boer; Dirk M Barends; Henderik W Frijlink
The therapeutic index of locally acting inhaled drugs as a function of their fine particle mass and particle size distribution: a literature review.
Current drug delivery 2008;5(2):142-7.
2007: Gerrit S Zijlstra; C A Brandsma; M F H Harpe; GM Van Dam; Dirk-Jan Slebos; Huib A M Kerstjens; Anne H de Boer; Henderik W Frijlink
Dry powder inhalation of hemin to induce heme oxygenase expression in the lung.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(3):667-75.
2007: Elsbeth M Westerman; Anne H de Boer; P P H Le Brun; Daan J Touw; A C Roldaan; Henderik W Frijlink; Harry G M Heijerman
Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2007;6(4):284-92.
2007: Elsbeth M Westerman; Anne H de Boer; P P H Le Brun; Daan J Touw; Henderik W Frijlink; Harry G M Heijerman
Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study.
International journal of pharmaceutics 2007;335(1-2):41-5.
2006: B H J Dickhoff; Anne H de Boer; Dorette Lambregts; Henderik W Frijlink
The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.
International journal of pharmaceutics 2006;327(1-2):17-25.
2006: Anne H de Boer; Paul Hagedoorn; Elsbeth M Westerman; P P H Le Brun; Harry G M Heijerman; Henderik W Frijlink
Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2006;28(3):171-8.
2006: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; J Goede; Henderik W Frijlink
Air classifier technology (ACT) in dry powder inhalation Part 3. Design and development of an air classifier family for the Novolizer multi-dose dry powder inhaler.
International journal of pharmaceutics 2006;310(1-2):72-80.
2006: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; J Goede; Henderik W Frijlink
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
International journal of pharmaceutics 2006;310(1-2):81-9.
2005: Anne H de Boer; B H J Dickhoff; Paul Hagedoorn; Doetie Gjaltema; J Goede; Dorette Lambregts; Henderik W Frijlink
A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation.
International journal of pharmaceutics 2005;294(1-2):173-84.
2005: B H J Dickhoff; Anne H de Boer; Dorette Lambregts; Henderik W Frijlink
The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2005;59(1):197-205.
2004: M Weda; Pieter Zanen; Anne H de Boer; Dirk M Barends; Henderik W Frijlink
An investigation into the predictive value of cascade impactor results for side effects of inhaled salbutamol.
International journal of pharmaceutics 2004;287(1-2):79-87.
2004: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; Dorette Lambregts; Meike Irngartinger; Henderik W Frijlink
The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler.
Pharmaceutical research 2004;21(12):2167-74.
2004: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; Dorette Lambregts; Meike Irngartinger; Henderik W Frijlink
The rate of drug particle detachment from carrier crystals in an air classifier-based inhaler.
Pharmaceutical research 2004;21(12):2158-66.
2004: Henderik W Frijlink; Anne H de Boer
Dry powder inhalers for pulmonary drug delivery.
Expert opinion on drug delivery 2004;1(1):67-86.
2004: Gerrit S Zijlstra; W L J Hinrichs; Anne H de Boer; Henderik W Frijlink
The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;23(2):139-49.
2004: Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; Henderik W Frijlink
Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
Die Pharmazie 2004;59(9):692-9.
2003: Anne H de Boer; Paul Hagedoorn; Henderik W Frijlink
The choice of a compressor for the aerosolisation of tobramycin (TOBI) with the PARI LC PLUS reusable nebuliser.
International journal of pharmaceutics 2003;268(1-2):59-69.
2003: B H J Dickhoff; Anne H de Boer; Dorette Lambregts; Henderik W Frijlink
The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2003;56(2):291-302.
2003: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; J Goede; K D Kussendrager; Henderik W Frijlink
Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.
International journal of pharmaceutics 2003;260(2):201-16.
2003: Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; J Goede; Henderik W Frijlink
Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures.
International journal of pharmaceutics 2003;260(2):187-200.
2002: M Weda; Pieter Zanen; Anne H de Boer; Doetie Gjaltema; A Ajaoud; Dirk M Barends; Henderik W Frijlink
Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy.
International journal of pharmaceutics 2002;249(1-2):247-55.
2002: Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; M Schaller; W Witt; Henderik W Frijlink
Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols.
International journal of pharmaceutics 2002;249(1-2):233-45.
2002: Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; Henderik W Frijlink
Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique.
International journal of pharmaceutics 2002;249(1-2):219-31.
2002: B H J Dickhoff; M J H Ellison; Anne H de Boer; Henderik W Frijlink
The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;54(2):245-8.
2002: P P H Le Brun; Anne H de Boer; G P M Mannes; D M I de Fraîture; RW Brimicombe; Daan J Touw; Alexander Vinks; Henderik W Frijlink; Harry G M Heijerman
Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;54(1):25-32.
2002: Anne H de Boer; P P H Le Brun; H G van der Woude; Paul Hagedoorn; Harry G M Heijerman; Henderik W Frijlink
Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;54(1):17-24.
2000: P P H Le Brun; Anne H de Boer; Harry G M Heijerman; Henderik W Frijlink
A review of the technical aspects of drug nebulization.
Pharmacy world & science : PWS 2000;22(3):75-81.
1999: P P H Le Brun; Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; Harry G M Heijerman; Henderik W Frijlink
Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.
International journal of pharmaceutics 1999;189(2):215-25.
1999: P P H Le Brun; Anne H de Boer; Doetie Gjaltema; Paul Hagedoorn; Harry G M Heijerman; Henderik W Frijlink
Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
International journal of pharmaceutics 1999;189(2):205-14.